Back

Antiviral activity of Cytomegalovirus-specific CD4+ T cells against lytically infected non-haemopoietic cells

Lim, E. Y.; Houldcroft, C. J.; Jackson, S. E.; Okecha, G.; Wills, M. R.

2022-12-11 immunology
10.1101/2022.12.08.519485 bioRxiv
Show abstract

HCMV establishes a lifelong latent infection in its host, eliciting a broad immune response involving both the innate and adaptive arms of immunity. In immunocompromised individuals, recovery of the HCMV-specific CD4+ T cell response is associated with a lower risk of HCMV reactivation and disease, suggesting that CD4+ T cells contribute significantly to control of viral replication in vivo. However, most prior studies of the HCMV-specific CD4+ T cell response have been performed with the aim of either predicting those at risk for HCMV reactivation and end-organ disease, or identifying markers which are associated with higher risk of HCMV viraemia. Few studies have examined the mechanisms of viral control of CD4+ T cells in response to cells lytically infected with HCMV. In this paper, we show that CD4+ T cells from a HCMV-seropositive donor can prevent viral dissemination in autologous fibroblasts, that the secretome from these cells is also antiviral, and that IFN-{gamma} is a key cytokine in the secretome. We also show that MHC Class II antigen presentation by monocytes was critical to driving this HCMV-specific CD4+ T cell response.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.